The Trump administration's Office of Management and Budget (OMB) is pushing forward with proposed federal funding rules that would let agencies cancel grants at any time over vague 'national interest' claims, sideline peer reviewers, and restrict research on culture-war topics. The rule, born from an August 2025 executive order and merged with other administration priorities through formal rulemaking, marks a significant escalation in the politicization of US research funding. While not directly aimed at crypto, the move could be a boon for decentralized science (DeSci) — blockchain-based grant mechanisms that offer researchers a transparent, censorship-resistant alternative.
What the proposed rules change
The core of the proposal is sweeping discretion: federal agencies could terminate any grant whenever they decide it's not in the 'national interest' — a term left intentionally vague. Political appointees would have final say, instructed not to 'routinely defer' to peer reviewers. The rules would also ban grants on certain culture war subjects, restrict international collaborations, and block spending on publishing papers and attending conferences.
📊 Market Data Snapshot
The OMB merged the executive order with other administration priorities and sent it through formal federal rulemaking to avoid court losses. That process is underway now, with a comment period likely later this year.
Why researchers might flee to DeSci
The rule makes federal grants unreliable. For a researcher counting on a multi-year NSF or NIH grant, the possibility of cancellation based on a shifting political wind is a dealbreaker. That's exactly the kind of uncertainty that pushes scientists toward alternative funding models — and crypto-native DeSci is the most promising one.
Projects like Gitcoin, Molecule, and VitaDAO already use on-chain crowdfunding, quadratic funding, and IP-NFTs to support research without government gatekeepers. If the OMB rule goes through, those models become more attractive. The tailwind for DeSci tokens like RSC and BIO could be real, though the sector remains small.
What most media missed
Crypto coverage tends to focus on SEC and CFTC actions, but the OMB rule threatens the pipeline of foundational academic research — cryptography, consensus mechanisms, privacy protocols like zk-SNARKs — that federal grants helped fund. NSF- and NIH-backed university projects have been a quiet engine for blockchain innovation. Disrupt that, and long-term technical development could slow.
International collaborations also take a hit. Multi-university blockchain research consortia like IC3 and Algorand's academic partnerships rely on cross-border teams. Cutting those ties could push talent and IP overseas, weakening US leadership in crypto R&D.
A historical precedent
The 2015 BitLicense rule from New York's DFS gave regulators broad discretion to deny licenses based on vague 'safety and soundness' and 'public interest' standards. The result: confusion, legal challenges, and capital flight — many crypto firms left New York. A similar dynamic could play out here: lawsuits are almost certain, and even if partially implemented, the rule will chill research in affected fields. For crypto, it's a second-order effect, but one worth watching.
The comment period hasn't opened yet, and legal challenges from universities and science advocacy groups are expected within weeks. If history holds, the rule faces injunctions before it ever takes effect — but the direction of travel is clear.
